Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE).
Front Cardiovasc Med
; 9: 953040, 2022.
Article
in En
| MEDLINE
| ID: mdl-35911507
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Front Cardiovasc Med
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: